Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Studies also show that tirzepatide may increase the risk of gallbladder disease
According to the FDA prescribing information for Wegovy, in the STEP clinical trials, cholelithiasis was reported in approximately 1.6% of semaglutide-treated patients compared to 0.7% of placebo recipients
Patients considering an investigational therapy should understand: The medication has not received FDA approval
Lustig RH, Christensen ML, Tosson HM, Velasquez-Mieyer PA, Arheart KL, Danish RK, Burghen GA: Racial dichotomy in the Body Mass Index (BMI) response to metformin pharmacotherapy for obesity/insulin resistance in children
US$ 21.95
US$ 26.34
US$ 27.13
US$ 21.40
US$ 22.48
US$ 25.48
US$ 25.82
US$ 20.33
US$ 22.38
US$ 21.79
US$ 25.26
US$ 23.73
